Clinical Trial Update: Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Hepatitis B immune globulin to interrupt maternal-to-infant transmission of Hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepatitis B immune globulin

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Hepatitis B, Hepatitis, Viral, Human | Phase 3 | Status: COMPLETED